GlaxoSmithKline Pharmaceuticals Ltd

Tax refund under Sec 143(1) AY 2025-2026

• Intimation under Sec 143(1) received for AY 2025-2026; refund of Rs 49,911,100.
• Refund credited to bank on 18 Aug 2026; intimation dated 19 Aug 2026.
• Tax refund to be recognised as Tax Paid Asset in Balance Sheet.
• No violations or contraventions mentioned in the filing.
• Signed by Ajay Nadkarni, VP Administration, Real Estate & Company Secretary.

Postal Ballot Objective

• Purpose: Ordinary resolutions for director appointment and MD re-appointment via postal ballot.
• Voting method: remote e-voting; window Aug 14 to Sep 13, 2026.
• Scrutinizer: Parikh & Associates; e-voting via KFintech.

Resolutions

• Resolution 1 (Ordinary): Appointment of Karine J F Natland as Non-Executive Director.
• Resolution 2 (Ordinary): Re-appoint Bhushan Akshikar as MD; 2-year term from 1 Dec 2026.

Director profiles

• Natland: Non-Executive Director; appointed 4 Aug 2026; retirement by rotation; independent background in APAC General Medicines.
• Akshikar: Managing Director since 2022; background in Janssen/J&J; MBA in Marketing.

Remuneration & Term

• MD remuneration: basic up to Rs 24,00,000 per month; bonus, LTI, perquisites up to 2.5x salary.
• Term details: Resolution 2 covers 1 Dec 2026 to 30 Nov 2028.
• Cut-off date for voting: 7 Aug 2026; eligibility to vote via e-voting.
• Results timeline: results to be announced by 15 Sep 2026.

Meeting Details

• Date: August 3, 2026; Time: not specified.
• Type/Mode: group earnings call, virtual conference.
• Event/Organiser: Q1 FY2027 Earnings Call (GlaxoSmithKline Pharmaceuticals Limited).
• Transcript: available on company website.

Participants

• Managing Director (GSK India)
• Chief Financial Officer (GSK India)

Purpose

• Earnings results discussion and portfolio update.
• Investor interactions during Q&A session.

Additional Notes

• Recording/presentation: transcript posted on company website.

Tax refund and final order

• Final order by ACIT Cir 7(1)(1) with Rs 23.21 Cr demand liability.
• Refund of Rs 52.00 Cr received on 6 Aug 2026.
• Refund pertains to AY 1984-85; OGE to CIT-Appeal dated 27 Jan 2026.
• Interest income of Rs 42.09 Cr on refund to be credited to P&L.
• No violations mentioned in connection with the orders.

Dematerialisation processing and listing status

• RTA processed dematerialisation requests for quarter ended 30 June 2026 and confirmed to depositories.
• Securities dematerialised have been listed on the stock exchanges where the existing securities are listed.
• Physical certificates were mutilated and cancelled after verification; depository name substituted as owner within 30 days.

AGM details

• AGM held on 30 June 2026 at 11:00 IST via VC/OAVM.
• Voting results and Scrutinizer’s report published on company and NSDL sites.

Key resolutions

• Adopt financial statements: Passed with majority; 99.48% in favour, 0.52% against.
• Dividend of Rs 57 per share approved; 99.99% in favour, 0.01% against.
• Re-appoint Subesh Williams: Passed with majority; 99.48% in favour, 0.52% against.
• Independent Directors' commission: Passed; 99.96% in favour, 0.04% against.
• Cost Auditor remuneration FY2026: Ratified; 100% in favour, 0% against.
• Cost Auditor remuneration FY2027: Ratified; 100% in favour, 0% against.